Historical record - last NADAC publication: 2/1/2021
Product Information
QUDEXY XR 50 MG CAPSULE is a brand product labeled by Upsher-Smith Laboratories LLC, priced at $11.1338 per EA under NDC 00245107230. Its NADAC has been published 179 times since Oct 17, 2018.
Strength
50 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245107230
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
2/1/2021
Active Ingredients
TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA205122On Market Since
4/11/2014
Pharmacological Classes
Price Statistics
The NADAC for QUDEXY XR 50 MG CAPSULE has been published 179 times since Oct 17, 2018, and over the history we have for it it has risen 18.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.1338 per EA |
|---|---|
| All-time high | $11.1338 (Mar 16, 2022) |
| All-time low | $9.3617 (Oct 17, 2018) |
| Median price | $10.5493 |
| Average price | $10.4743 |
| Largest weekly change | +6.0% (Feb 3, 2021) |
| Weeks tracked | 179 |
| Tracking since | Oct 17, 2018 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QUDEXY XR 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QUDEXY XR 50 MG CAPSULE, manufactured by Upsher-Smith Laboratories LLC, is $11.1338 per EA (NDC 00245107230), effective Mar 16, 2022.
How has the price of QUDEXY XR 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QUDEXY XR 50 MG CAPSULE has risen 18.9%. It has been tracked across 179 weekly CMS publications since Oct 17, 2018.
What are the highest and lowest recorded NADAC prices for QUDEXY XR 50 MG CAPSULE?
Since Oct 17, 2018, the NADAC for QUDEXY XR 50 MG CAPSULE has ranged from a low of $9.3617 (Oct 17, 2018) to a high of $11.1338 (Mar 16, 2022), with a median of $10.5493 per EA.
Are there cheaper alternatives to QUDEXY XR 50 MG CAPSULE?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 50 MG TABLET, is $0.0345 per EA — about 100% below QUDEXY XR 50 MG CAPSULE.
Who manufactures QUDEXY XR 50 MG CAPSULE?
QUDEXY XR 50 MG CAPSULE (NDC 00245107230) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification